Alexandra Pichl
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations.
Journal: The European respiratory journal
Published: May 09, 2022
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
Journal: Nature metabolism
Published: July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
Journal: Nature metabolism
Published: February 25, 2020
Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice.
Journal: British journal of pharmacology
Published: May 03, 2019
Riociguat for treatment of pulmonary hypertension in COPD: a translational study.
Journal: The European respiratory journal
Published: October 26, 2018
Exercise training reverses inflammation and muscle wasting after tobacco smoke exposure.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology
Published: November 03, 2017
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.
Journal: American journal of respiratory and critical care medicine
Published: April 18, 2014
Impact of S-adenosylmethionine decarboxylase 1 on pulmonary vascular remodeling.
Journal: Circulation
Published: January 29, 2014
Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD.
Journal: Disease models & mechanisms
Published: September 19, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026